|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-02
|
$387,195
|
$387,195
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$29,488
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SPARC as a regulator of collagen signaling in Pancreatic Cancer
|
5F31CA168350-03
|
$30,485
|
$30,485
|
AGUILERA, KRISTINA
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
|
5R01CA164964-02
|
$593,181
|
$593,181
|
AHN, JIYOUNG
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
5R01CA185357-02
|
$490,967
|
$490,967
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Elucidating the role and regulation of epithelial plasticity in metastasis
|
5F31CA177163-02
|
$29,766
|
$29,766
|
AIELLO, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$430,051
|
$21,503
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
$113,359
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$51,835
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Mesothelin-targeted immunotoxins in Pancreatic Cancer
|
ZIA BC 011652
|
$342,411
|
$342,411
|
Alewine, Christine
|
CCR (NCI)
|
|
Clinical Support
|
ZIE BC 011653
|
$18,022
|
$1,802
|
Alewine, Christine
|
CCR (NCI)
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
1R01CA198074-01
|
$392,629
|
$392,629
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
5R01CA182076-02
|
$437,758
|
$437,758
|
ALLEN, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
MYC is a critical downstream effector in KRAS-driven pancreatic cancer
|
1F32CA192769-01
|
$56,529
|
$56,529
|
ALLEN-PETERSEN, BRITTANY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,717,771
|
$85,889
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
$1,387
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
$25,783
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
$2,500
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
$6,223
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
5R01CA169134-03
|
$312,942
|
$78,236
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$38,442
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
LTG_Amundadottir
|
ZIA CP010201 - 10569
|
$329,285
|
$230,500
|
Amundadottir, Laufey
|
DCEG (NCI)
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
2U54CA132384-06A1
|
$1,266,713
|
$456,017
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
Reversing Cellular immortality in cancer
|
1R35CA197563-01
|
$632,529
|
$253,012
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$461,571
|
$230,786
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$2,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$4,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$7,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$6,344
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$291,719
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Integrative approaches to elucidate p53 transcriptional networks during carcinoge
|
1R35CA197591-01
|
$832,842
|
$832,842
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Mouse Models to Dissect p53 Tumor Suppressor Function
|
5R01CA140875-05
|
$344,875
|
$344,875
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Targeting PAK4 for Overcoming Drug Resistance in Pancreatic Cancer
|
1R21CA188818-01A1
|
$199,285
|
$199,285
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
|
1R01CA183101-01A1
|
$684,278
|
$684,278
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Genetic and pharmacological manipulation of system xc in pancreatic cancer
|
5F31CA180738-02
|
$43,120
|
$43,120
|
BADGLEY, MICHAEL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Finding Novel Pancreatic Cancer Oncogenes Using an Innovative 3D Culture System
|
1F32CA192904-01
|
$54,194
|
$54,194
|
BAKER, LINDSEY
|
COLD SPRING HARBOR LABORATORY
|
|
Defining the Role and Mechanism of Pak1 in Supporting Pancreatic Cancer
|
5F31CA180628-02
|
$27,120
|
$27,120
|
BAKER, NICOLE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The Role of p120ctn in Pancreatic Ductal Morphogenesis and Adenocarcinoma
|
5F30CA180601-02
|
$29,766
|
$29,766
|
BAKIR, BASIL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Genomic Landscape of Pancreatic Cancer Metastasis
|
1F32CA192761-01
|
$52,406
|
$52,406
|
BALLI, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
|
Functional Significance of CD133 in Pancreatic Cancer
|
5R01CA184274-02
|
$315,400
|
$315,400
|
BANERJEE, SULAGNA
|
UNIVERSITY OF MINNESOTA
|
|
Mechanisms of Signal Transduction by Ras Proteins
|
5R01CA055360-23
|
$409,825
|
$409,825
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy
|
ZIA BC 010451
|
$197,282
|
$98,641
|
Barchi, Joseph
|
CCR (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-02
|
$1,549,280
|
$77,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$170,616
|
$17,062
|
Bates, Susan
|
CCR (NCI)
|
|
Targeted Radiation Therapy for Pancreatic Cancer
|
1R01CA195586-01A1
|
$435,945
|
$435,945
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Targeting Mucin and EGFR Axis in Pancreatic Cancer
|
5R01CA183459-02
|
$311,659
|
$311,659
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Pancreatic Tumor Micro-environment Network
|
5U54CA163120-05
|
$938,351
|
$938,351
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
CD40 Pathway in Pancreatic Adenocarcinoma
|
5K08CA138907-05
|
$162,462
|
$162,462
|
BEATTY, GREGORY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
2P30CA042014-26
|
$1,639,000
|
$81,950
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
Total relevant funding to Pancreas for this search: $125,247,562
|